GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Net Policyholder Benefits/Claims

Biosergen AB (OSTO:BIOSGN) Net Policyholder Benefits/Claims


View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Biosergen AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a clinical stage biotechnology company advancing the treatment of life-threatening fungal infections. Biosergen' s mission is to develop the drug candidate BSG005 into a superior antifungal therapy with broader efficacy and improved safety over existing treatments. BSG005 potential is to eliminate fungal infections rather than just slowing their growth, reducing the risk of resistance.